31 August 2020 : Database Analysis
A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer
Zheyu Zhang1AE, Bin Li2B, Jianhua Huang3C, Siqi Huang1B, Dan He3D, Weijun Peng1FG*, Sifang Zhang1GDOI: 10.12659/MSM.923327
Med Sci Monit 2020; 26:e923327
Table 4 Virtual docking of 4 representative ingredients from Zuojinwan for gastric cancer targets.
| Compound | Binding energy/(kcal·mol−1) | ||
|---|---|---|---|
| MMP9 | MMP3 | MMP1 | |
| Original ligands | −7.9091 | −11.8849 | −14.5777 |
| Berberine | −5.8617 | −5.6970 | −5.7199 |
| Isorhamnetin | −5.8996 | −7.3793 | −7.1915 |
| Quercetin | −6.1569 | −7.2459 | −7.1467 |
| Wogonin | −6.4024 | −5.7839 | −5.9911 |
| (R)-Canadine | −5.1318 | −6.2006 | −5.6461 |
| Baicalein | −4.9929 | −5.7758 | −6.3437 |
| Baicalin | −7.5559 | −7.0784 | −7.4166 |
| Berlambine | −5.5981 | −7.0967 | −5.5062 |
| Evodiamine | −5.1372 | −6.1891 | −5.3646 |
| MMP – matrix metalloproteinases. | |||